Next Article in Journal
Structure and Stability of C:H:O Plasma Polymer Films Co-Polymerized Using Dimethyl Carbonate
Next Article in Special Issue
The Canady Helios Cold Plasma Scalpel Significantly Decreases Viability in Malignant Solid Tumor Cells in a Dose-Dependent Manner
Previous Article in Journal
Polymerization of D-Ribose in Dielectric Barrier Discharge Plasma
Previous Article in Special Issue
Possible Mechanism of Glucose Uptake Enhanced by Cold Atmospheric Plasma: Atomic Scale Simulations
Open AccessReview

New Hopes for Plasma-Based Cancer Treatment

1
Institute of Innovation for Future Society, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan
2
Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Tsurumai-cho 65, Showa-ku, Nagoya 466-8550, Japan
3
Plasma Nanotechnology Research Center, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan
4
Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Tsurumai-cho 65, Showa-ku, Nagoya 466-8550, Japan
5
Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-cho 65, Showa-ku, Nagoya 466-8550, Japan
*
Author to whom correspondence should be addressed.
Plasma 2018, 1(1), 150-155; https://doi.org/10.3390/plasma1010014
Received: 30 July 2018 / Revised: 9 August 2018 / Accepted: 16 August 2018 / Published: 18 August 2018
(This article belongs to the Special Issue Plasma Medicine)
Non-thermal plasma represents a novel approach in cancer treatment. Both direct and indirect plasma treatments are available, with clinical trials of direct plasma treatment in progress. Indirect treatments involve chemotherapy (i.e., plasma-activated medium) and immunotherapy. Recent studies suggest that integrated plasma treatments could be an extremely effective approach to cancer therapy. View Full-Text
Keywords: plasma cancer treatment; plasma-activated medium (PAM); plasma-assisted immunotherapy plasma cancer treatment; plasma-activated medium (PAM); plasma-assisted immunotherapy
Show Figures

Figure 1

MDPI and ACS Style

Tanaka, H.; Mizuno, M.; Ishikawa, K.; Toyokuni, S.; Kajiyama, H.; Kikkawa, F.; Hori, M. New Hopes for Plasma-Based Cancer Treatment. Plasma 2018, 1, 150-155.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Back to TopTop